Company intelligence / Profile preview

Centrapharm

Etten-Leur, North Brabant, Netherlands

Ownership: Private
Development stage: Other

Overview

Centrapharm is a prominent Dutch pharmaceutical company specializing in the marketing and distribution of generic medicines and over-the-counter (OTC) healthcare products. Operating as a subsidiary of the STADA Group, the company provides a broad portfolio of high-quality, affordable therapeutic solutions to the Dutch market. Its offerings span numerous medical categories, including cardiovascular health, central nervous system disorders, and pain management. Centrapharm plays a critical role in the healthcare supply chain by ensuring the availability of essential medications for pharmacies, hospitals, and patients.

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesGastroenterologyPsychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Centrapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrapharm.

Explore the full profile